Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Ca2+ channel antagonist
DRUG CLASS:
Ca2+ channel antagonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
amlodipine/celecoxib (1)
amlodipine/atorvastatin (1)
tetrandrine (0)
papaverine (0)
amlodipine/celecoxib (1)
amlodipine/atorvastatin (1)
tetrandrine (0)
papaverine (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Colon Cancer
No biomarker
Colon Cancer
amlodipine/celecoxib
Resistant: B - Late Trials
amlodipine / celecoxib
Resistant
:
B
amlodipine/celecoxib
Resistant: B - Late Trials
amlodipine / celecoxib
Resistant
:
B
CAV1 expression
Non Small Cell Lung Cancer
CAV1 expression
Non Small Cell Lung Cancer
amlodipine/atorvastatin
Sensitive: D – Preclinical
amlodipine / atorvastatin
Sensitive
:
D
amlodipine/atorvastatin
Sensitive: D – Preclinical
amlodipine / atorvastatin
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login